DiscoverBlind Spot - The Eye Doctor's Podcast44. The ZEDS Trial - How Should We Treat Zoster? (Dr. Benny Jeng)
44. The ZEDS Trial - How Should We Treat Zoster? (Dr. Benny Jeng)

44. The ZEDS Trial - How Should We Treat Zoster? (Dr. Benny Jeng)

Update: 2025-10-191
Share

Description

In this episode, Zale sits down with Dr. Benny Jeng, head of the ZEDS study which investigated the role of longer time antiviral treatmetn for patients with HZO with ocular involvement.  They review the results of the study and disuss whether long term oral antivirals reduces zoster recurrences and the severity and duration of post-herpetic neuralgia. 

This episode is sponsored by Thea Pharma Canada - https://www.theapharma.ca

Become a supporter of this podcast: https://www.spreaker.com/podcast/blind-spot-the-eye-doctor-s-podcast--5819306/support.
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

44. The ZEDS Trial - How Should We Treat Zoster? (Dr. Benny Jeng)

44. The ZEDS Trial - How Should We Treat Zoster? (Dr. Benny Jeng)

Zale Mednick